J&J discontinues dengue drug study after changes in R&D portfolio
Johnson & Johnson said it will discontinue a mid-stage field study evaluating the efficacy of its experimental pill for the prevention of dengue.
Source link
- Jim Cramer says strong jobs report suggests no imminent recession — and that’s good for stocks
- Why is the UK handing the Chagos Islands back to Mauritius?
